"non small lung cancer" trang 15 - tải miễn phí từ tailieunhanh
Rationale and protocol design of a phase II study of first-line osimertinib treatment for patients with poor performance status and EGFR mutation-positive non-small cell lung cancer (OPEN/TORG2040)

Rationale and protocol design of a phase II study of first-line osimertinib treatment for patients with poor performance status and EGFR mutation-positive non-small cell lung cancer (OPEN/TORG2040)
6    8    1
EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage

EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage
18    8    1
Phase II study of carboplatin/nab-paclitaxel/ atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial

Phase II study of carboplatin/nab-paclitaxel/ atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial
5    1    1
Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: A study based on the SEER database and a Chinese cohort

Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: A study based on the SEER database and a Chinese cohort
13    1    1
Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1–4 brain metastases

Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1–4 brain metastases
14    1    1
Association between the efcacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: A retrospective study

Association between the efcacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: A retrospective study
10    1    1
Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: A multicenter prospective study

Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: A multicenter prospective study
11    1    1
Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis

Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis
14    1    1
First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFRmutated non-small cell Lung cancer with brain metastases: A systematic review and meta-analysis

First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFRmutated non-small cell Lung cancer with brain metastases: A systematic review and meta-analysis
11    3    1
Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: A multicenter study

Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: A multicenter study
9    4    1
LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR433-3p to upregulate WTAP

LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR433-3p to upregulate WTAP
11    37    1
NDRG1 downregulates ATF3 and inhibits cisplatininduced cytotoxicity in lung cancer A549 cells

NDRG1 downregulates ATF3 and inhibits cisplatininduced cytotoxicity in lung cancer A549 cells
6    69    0
Improving lung cancer survival; time to move on

Improving lung cancer survival; time to move on
4    49    1
Solitary multicystic lesion lung cancer: Two case reports and review of the literature

Solitary multicystic lesion lung cancer: Two case reports and review of the literature
5    59    1
High expression of AGR2 in lung cancer is predictive of poor survival

High expression of AGR2 in lung cancer is predictive of poor survival
9    22    1
Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT

Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT
15    71    1
A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer

A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer
8    85    0
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): An open-label, non-randomized, multicenter, phase IV clinical trial

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): An open-label, non-randomized, multicenter, phase IV clinical trial
7    72    1
Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study

Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study
10    48    0
Modulation the crosstalk between tumorassociated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2

Modulation the crosstalk between tumorassociated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2
12    62    1